Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verastem Inc shares valued at $36,069 were purchased by Dan Paterson on Jan 12 ’26. At $7.16 per share, Dan Paterson acquired 5,039 shares.
Also, Dan Paterson purchased 10,321 shares, netting a total of over 73,851 in proceeds.
Before that, Paterson Dan had sold 10,321 shares from its account. In a trade valued at $73,898, the President and CEO traded Verastem Inc shares for $7.16 each. Upon closing the transaction, the insider’s holdings decreased to 10,321 shares, worth approximately $2.64 million.
Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of March 24, 2025, H.C. Wainwright has reiterated its “Buy” rating for VSTM. Earlier on December 31, 2024, BTIG Research resumed its rating. Their recommendation was “a Buy” for VSTM stock.
Analyzing VSTM Stock Performance
On last trading session, Verastem Inc [NASDAQ: VSTM] plunged -2.80% to $6.6. The stock’s lowest price that day was $6.59, but it reached a high of $7.03 in the same session. During the last five days, there has been a drop of approximately -16.14%. Over the course of the year, Verastem Inc shares have jumped approximately 30.95%.
Support And Resistance Levels for Verastem Inc (VSTM)
RSI (Relative Strength Index) is 33.44 on the 14-day chart, showing neutral technical sentiment.
Is Verastem Inc subject to short interest?
Stocks of Verastem Inc saw a sharp steep in short interest on 2025-12-31 dropping by -1.38 million shares to 17.02 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 18.39 million shares. A decline of -8.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.93 of the overall float, the days-to-cover ratio (short ratio) decline to 9.93.
Which companies own the most shares of Verastem Inc (VSTM)?
In terms of Verastem Inc share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 106.19% from the previous closing price of $6.79. Analysts anticipate Verastem Inc stock to reach 15 by 2026, with the lowest price target being 13. In spite of this, 5 analysts ranked Verastem Inc stock as Buy at the end of 2026. On September 30, 2024, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $13.
